Seven patients (6%) developed grade 3 hepatotoxicity (AST: 3 patients, ALT: 1, ALP: 5, bilirubin: 2) and 2 patients experienced grade 4 hepatotoxicity (one patient with hyperbilirubinemia and one with elevated AST). Here, GPT is linked to Hyperbilirubinemia.